An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

Asaf Wyszynski, Chi-Chen Hong, Kristin Lam, Kyriaki Michailidou, Christian Lytle, Song Yao, Yali Zhang, Manjeet K. Bolla, Qin Wang, Joe Dennis, John L. Hopper, Melissa C. Southey, Marjanka K. Schmidt, Annegien Broeks, Kenneth Muir, Artitaya Lophatananon, Peter A. Fasching, Matthias W. Beckmann, Julian Peto, Isabel Dos-Santos-SilvaElinor J. Sawyer, Ian Tomlinson, Barbara Burwinkel, Frederik Marme, Pascal Guénel, Thérèse Truong, Stig E. Bojesen, Børge G. Nordestgaard, Anna González-Neira, Javier Benitez, Susan L. Neuhausen, Hermann Brenner, Aida Karina Dieffenbach, Alfons Meindl, Rita K. Schmutzler, Hiltrud Brauch, Heli Nevanlinna, Sofia Khan, Keitaro Matsuo, Hidemi Ito, Thilo Dörk, Natalia V. Bogdanova, Annika Lindblom, Sara Margolin, Arto Mannermaa, Veli Matti Kosma, Anna H. Wu, David Van Den Berg, Diether Lambrechts, Paolo Radice, GENICA Network

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression'. Together they form a unique fingerprint.

Medicine & Life Sciences